|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiac Transplantation and Mechanical Circulatory Support, Medical City Dallas Hospital, 7777 Forest Ln, Ste A323, Dallas, TX 75230
(Email: tdewey@csant.com).
| The first 20% of the full text of this article appears below. |
Historically, operative mortality has been the measuring stick by which varying techniques, procedures, or therapies are compared. Death has the benefit of being a well-defined end point with generally little ambiguity. But as we attempt to reconcile novel therapies, such as transcatheter aortic valve implantation to more conventional approaches, different metrics of success in addition to death will likely need to be considered.
Survival—both immediate and long-term—is an important measure of success, particularly between matched populations. But other performance measures, such as duration of hospitalization, time to return to work or normal activity, discharge to a nonhome environment, and resource utilization, can be increasingly important indicators of therapeutic success when evaluating outcomes among diverse populations. It is intuitive that different populations might have diverse treatment and outcome
Related Article
Ann. Thorac. Surg. 2010 89: 751-756.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |